表紙:睡眠時無呼吸症候群治療・診断機器の世界市場:考察と予測、および新型コロナウイルス感染症(COVID-19)の影響(2020年~2024年)
市場調査レポート
商品コード
933899

睡眠時無呼吸症候群治療・診断機器の世界市場:考察と予測、および新型コロナウイルス感染症(COVID-19)の影響(2020年~2024年)

Global Sleep Apnea Therapeutic & Diagnostic Devices Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 113 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
睡眠時無呼吸症候群治療・診断機器の世界市場:考察と予測、および新型コロナウイルス感染症(COVID-19)の影響(2020年~2024年)
出版日: 2020年04月30日
発行: Koncept Analytics
ページ情報: 英文 113 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

睡眠時無呼吸症候群の治療機器と診断機器の市場は、医療機器の普及拡大、閉塞性睡眠時無呼吸(OSA)の有病率の上昇、高齢者人口の増加、医療技術の研究開発費の増加、肥満の増加などの要因に促され、2020年から2024年まで7.94%のCAGRで成長し、92億9,000万米ドルに達する見通しです。持続陽圧呼吸療法(CPAP)機器の費用と副作用の問題、厳格な規制など市場の成長を妨げる要因はあるものの、人工知能(AI)技術の開発に取り組んでいる企業への投資拡大、遠隔医療に対する関心の高まり、舌下神経刺激(HNS)機器の開発、睡眠の診断を行うアクティグラフィーの導入拡大など注目すべき動きも見られます。

当レポートは、世界の睡眠時無呼吸症候群の治療機器と診断機器の市場を調査したもので、COVID-19の影響、世界市場と地域市場の分析、市場の力学、競合情勢、企業プロフィアルなどの情報を提供しています。

目次

第1章 概要

  • イントロダクション
  • 睡眠時無呼吸症候群の危険因子
  • 睡眠時無呼吸症候群の種類
  • 睡眠時無呼吸症候群の診断と治療
  • 睡眠時無呼吸症候群の医療機器
  • 持続陽圧呼吸療法(CPAP)

第2章 COVID-19の影響

  • COVID-19症例数の増加
  • 政府の医療費支出の増加
  • 医療分野におけるモノのインターネット(IoT)導入の加速
  • 各地域への影響

3. 世界市場の分析

  • 金額ベースの市場分析
  • 数量ベースの市場分析
  • タイプ別の分析
    • 睡眠時無呼吸症候群治療機器
    • 睡眠時無呼吸症候群診断機器
    • 睡眠ポリグラフ検査(PSG)機器
  • 各地域の市場

第4章 地域市場の分析

  • 北米
    • 米国
  • 欧州
    • ドイツ
    • 英国
  • アジア太平洋
  • その他

第5章 市場の力学

  • 成長促進要因
    • 医療機器の拡大
    • 閉塞性睡眠時無呼吸(OSA)の有病率の上昇
    • 高齢者人口の増加
    • 医療技術の研究開発費の増加
    • 肥満の増加
    • 急速な都市化
    • 医療費の急増
    • 睡眠時無呼吸症候群と関連する併存症に対する意識の高まり
  • 主なトレンドと開発
    • 人工知能(AI)関連の新興企業に対する投資の増加
    • 遠隔医療への関心の高まり
    • 舌下神経刺激療法(HNS)の開発
    • アクティグラフィーの普及拡大
  • 課題
    • 持続陽圧呼吸療法(CPAP)機器の高コスト
    • CPAP療法に伴う副作用
    • 各国政府の厳格な規制

第6章 競合情勢

  • 世界の市場
    • 主要企業の収益比較
    • 主要企業の研究開発支出の比較
    • 主要企業の時価総額の比較
    • 主要企業の製品ポートフォリオ

第7章 企業プロファイル

  • Koninklijke Philips
    • 事業の概要
    • 財務概要
    • 事業戦略
  • ResMed
  • Invacare Corporation
  • Fisher & Paykel
  • Somnomed Ltd.
  • BMC Medical
図表

List of Figures

  • Potential Etiological Risk Factors for Sleep Apnea
  • Types of Sleep Apnea
  • Sleep Apnea Devices
  • The U.S. Government Share of Healthcare Spending (2020-2027)
  • Global Healthcare IoT Device Installation Forecast (2017-2021)
  • Global Sleep Apnea Device Market by Value (2015-2019)
  • Global Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Global Sleep Apnea Device Market by Type (2019)
  • Global Therapeutic Sleep Apnea Device Market by Value (2015-2019)
  • Global Therapeutic Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Global Diagnostic Sleep Apnea Device Market by Value (2015-2019)
  • Global Diagnostic Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Global Diagnostic Sleep Apnea Device Market by Device Type (2019)
  • Global Polysomnography (PSG) device Market Forecast by Value (2019-2024)
  • Global Sleep Apnea Device Market by Region (2019)
  • North America Sleep Apnea Device Market by Value (2015-2019)
  • North America Sleep Apnea Device Market Forecast by Value (2020-2024)
  • North America Sleep Apnea Device Market by Region (2019)
  • The U.S. Sleep Apnea Device Market by Value (2015-2019)
  • The U.S. Sleep Apnea Device Market Forecast by Value (2020-2024)
  • The U.S. Sleep Apnea Device Market by Product Type (2019)
  • The U.S. Therapeutic Sleep Apnea Device Market by Value (2015-2019)
  • The U.S. Therapeutic Sleep Apnea Device Market Forecast by Value (2020-2024)
  • The U.S. Diagnostic Sleep Apnea Device Market by Value (2015-2019)
  • The U.S. Diagnostic Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Europe Sleep Apnea Device Market by Value (2015-2019)
  • Europe Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Europe Sleep Apnea Device Market by Region (2019)
  • Germany Sleep Apnea Device Market by Value (2015-2019)
  • Germany Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Germany Sleep Apnea Device Market by Product Type (2019)
  • Germany Therapeutic Sleep Apnea Device Market by Value (2015-2019)
  • Germany Therapeutic Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Germany Diagnostic Sleep Apnea Device Market by Value (2015-2019)
  • Germany Diagnostic Sleep Apnea Device Market Forecast by Value(2020-2024)
  • The U.K. Sleep Apnea Device Market by Value (2015-2019)
  • The U.K. Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Asia-Pacific Sleep Apnea Device Market by Value (2015-2019)
  • Asia-Pacific Sleep Apnea Device Market Forecast by Value (2020-2024)
  • ROW Sleep Apnea Device Market by Value (2015-2019)
  • ROW Sleep Apnea Device Market Forecast by Value (2020-2024)
  • Global Medical Device Market (2019-2024)
  • Obstructive Sleep Apnea Population by Top 10 Countries (2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Medical Technology R&D Spending (2015-2019)
  • Shares of Obese Population by Major Countries (2000-2030)
  • Global Urban Population (2015-2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Artificial Intelligence (AI) Startup Funding (2015-2019)
  • Global Telehealth Patient Population (2015-2019)
  • Koninklijke Philips Sales and Net Income (2015-2019)
  • Koninklijke Philips Sales by Segments (2019)
  • Koninklijke Philips Sales by Regions (2019)
  • ResMed Net Revenue and Net Income (2015-2019)
  • ResMed Net Revenue by Segments (2019)
  • ResMed Net Revenue by Regions (2019)
  • Invacare Corporation Net Sales and Net Loss (2015-2019)
  • Invacare Corporation Net Sales by regions (2019)
  • Fisher & Paykel Revenue and Profit (2015-2019)
  • Fisher & Paykel Revenue by Business Units (2019)
  • Fisher & Paykel Revenue by Regions (2019)
  • Somnomed Ltd. Revenue and Net Loss (Profit) (2015-2019)
  • Somnomed Ltd. Revenue by Regions (2019)

List of Tables

  • Global COVID-19 Cases by Income Group
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
  • Key Players - Sleep Apnea Product Portfolio
目次

The global sleep apnea device market is expected to record a value of US$9.29 billion in 2024, growing at a CAGR of 7.94%, for the duration spanning 2020-2024. The factors such as expansion of medical devices, rising prevalence of obstructive sleep apnea (OSA), growth in the geriatric population, increasing medical technology R&D spending and rise in obesity would drive the growth of the market. However, the market growth would be challenged by high cost of CPAP, side effects associated with CPAP and stringent regulations. A few notable trends may include, rising investment in Artificial Intelligence (AI) startups, increasing focus on Telehealth, development of Hypoglossal Nerve Stimulation (HNS) and rising adoption of actigraphy diagnostic devices.

The global sleep apnea market has emerged out as very strong because of the rising number of sleep apnea cases across the world. The market is covered with a wide range of diagnostic as well as therapeutic devices. Positive Airway Pressure (PAP) devices are the widely used therapeutic method in the sleep apnea space because of the highly effective results. Rising awareness about sleep apnea and related comorbidities among people is playing a significant role in persuading people to undergo diagnosis as well as treatment therapies.

The fastest growing regional market was North America with the highest incidence of obstructive sleep apnea cases. The U.S. has accounted for the highest share in the North America market due to the technological advances in mask designs, improved designs of CPAP and enhanced support services for PAP. Further, Europe has also evolved out as a prominent market with the increased pool of untreated sleep apnea patients. Both the regions have considerable growth potentials that would help in the expansion of the global sleep apnea market in coming years.

Scope of the report:

The report provides a comprehensive analysis of the global sleep apnea therapeutic & diagnostic devices market.

The major regional markets (North America, Europe, Asia-Pacific and ROW), along with the country coverage of the U.S., Germany and the U.K. have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Koninklijke Philips, ResMed, Invacare Corporation, Fisher & Paykel, Somnomed Ltd. and BMC Medical) are also presented in detail.

Key Target Audience:

  • Sleep Apnea Devices Manufacturers
  • Medical Technology & Artificial Intelligence Firms
  • End Users (Hospitals, Sleeping Centers, Clinics, Testing Labs)
  • Investment Banks
  • Healthcare and Medical Consultants
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1 Introduction
  • 1.2 Risk Factors For Sleep Apnea
  • 1.3 Types of Sleep Apnea
  • 1.4 Diagnosis and Treatment of Sleep Apnea
  • 1.5 Sleep Apnea Devices
  • 1.6 Continuous Positive Airway Pressure (CPAP)

2. Impact of COVID-19

  • 2.1 Rise in Number of COVID-19 Cases
  • 2.2 Growth in Government Spending on Healthcare
  • 2.3 Acceleration in Healthcare Internet of Thing (IoT)
  • 2.4 Regional Impact

3.Global Market Analysis

  • 3.1 Global Sleep Apnea Device Market by Value
  • 3.2 Global Sleep Apnea Device Market Forecast by Value
  • 3.3 Global Sleep Apnea Device Market by Type
    • 3.3.1 Global Therapeutic Sleep Apnea Device Market by Value
    • 3.3.2 Global Therapeutic Sleep Apnea Device Market Forecast by Value
    • 3.3.3 Global Diagnostic Sleep Apnea Device Market by Value
    • 3.3.4 Global Diagnostic Sleep Apnea Device Market Forecast by Value
    • 3.3.5 Global Diagnostic Sleep Apnea Device Market by Device Type
    • 3.3.6 Global Polysomnography (PSG) device Market Forecast by Value
  • 3.4 Global Sleep Apnea Device Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Sleep Apnea Device Market by Value
    • 4.1.2 North America Sleep Apnea Device Market Forecast by Value
    • 4.1.3 North America Sleep Apnea Device Market by Region
    • 4.1.4 The U.S. Sleep Apnea Device Market by Value
    • 4.1.5 The U.S. Sleep Apnea Device Market Forecast by Value
    • 4.1.6 The U.S. Sleep Apnea Device Market by Product Type
    • 4.1.7 The U.S. Therapeutic Sleep Apnea Device Market by Value
    • 4.1.8 The U.S. Therapeutic Sleep Apnea Device Market Forecast by Value
    • 4.1.9 The U.S. Diagnostic Sleep Apnea Device Market by Value
    • 4.1.10 The U.S. Diagnostic Sleep Apnea Device Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Sleep Apnea Device Market by Value
    • 4.2.2 Europe Sleep Apnea Device Market Forecast by Value
    • 4.2.3 Europe Sleep Apnea Device Market by Region
    • 4.2.4 Germany Sleep Apnea Device Market by Value
    • 4.2.5 Germany Sleep Apnea Device Market Forecast by Value
    • 4.2.6 Germany Sleep Apnea Device Market by Product Type
    • 4.2.7 Germany Therapeutic Sleep Apnea Device Market by Value
    • 4.2.8 Germany Therapeutic Sleep Apnea Device Market Forecast by Value
    • 4.2.9 Germany Diagnostic Sleep Apnea Device Market by Value
    • 4.2.10 Germany Diagnostic Sleep Apnea Device Market Forecast by Value
    • 4.2.11 The U.K. Sleep Apnea Device Market by Value
    • 4.2.12 The U.K. Sleep Apnea Device Market Forecast by Value
  • 4.3 Asia-Pacific
    • 4.3.1 Asia-Pacific Sleep Apnea Device Market by Value
    • 4.3.2 Asia-Pacific Sleep Apnea Device Market Forecast by Value
  • 4.4 ROW
    • 4.4.1 ROW Sleep Apnea Device Market by Value
    • 4.4.2 ROW Sleep Apnea Device Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Expansion of Medical Device
    • 5.1.2 Rising Prevalence of Obstructive Sleep Apnea (OSA)
    • 5.1.3 Growth in Geriatric Population
    • 5.1.4 Increasing Medical Technology R&D Spending
    • 5.1.5 Rise in Obesity
    • 5.1.6 Rapid Urbanization
    • 5.1.7 Upsurge in Healthcare Expenditures
    • 5.1.8 Growing Awareness about Sleep Apnea and Related Comorbidities
  • 5.2 Key Trends and Developments
    • 5.2.1 Rising Investment in Artificial Intelligence (AI) Startups
    • 5.2.2 Increasing Focus on Telehealth
    • 5.2.3 Development of Hypoglossal Nerve Stimulation (HNS)
    • 5.2.4 Rising Adoption of Actigraphy Diagnostic Devices
  • 5.3 Challenges
    • 5.3.1 High Cost of Continuous Positive Airway Pressure (CPAP) Machines
    • 5.3.2 Side Effects Associated with CPAP Therapy
    • 5.3.3 Stringent Government Regulations

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Key Players - Revenue Comparison
    • 6.1.2 Key Players - R&D Expenditure Comparison
    • 6.1.3 Key Players - Market Capitalization Comparison
    • 6.1.4 Key Players - Sleep Apnea Product Portfolio

7. Company Profiles

  • 7.1 Koninklijke Philips
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 ResMed
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Invacare Corporation
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Fisher & Paykel
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Somnomed Ltd.
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 BMC Medical
    • 7.6.1 Business Overview
    • 7.6.2 Business Strategies